chr1-196779849-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_021023.6(CFHR3):c.306A>G(p.Arg102=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 26)
Consequence
CFHR3
NM_021023.6 synonymous
NM_021023.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.348
Genes affected
CFHR3 (HGNC:16980): (complement factor H related 3) The protein encoded by this gene is a secreted protein, which belongs to the complement factor H-related protein family. It binds to heparin, and may be involved in complement regulation. Mutations in this gene are associated with decreased risk of age-related macular degeneration, and with an increased risk of atypical hemolytic-uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 1-196779849-A-G is Benign according to our data. Variant chr1-196779849-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 748796.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.348 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.306A>G | p.Arg102= | synonymous_variant | 3/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.306A>G | p.Arg102= | synonymous_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.306A>G | p.Arg102= | synonymous_variant | 3/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.306A>G | p.Arg102= | synonymous_variant | 3/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.306A>G | p.Arg102= | synonymous_variant | 3/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.306A>G | p.Arg102= | synonymous_variant, NMD_transcript_variant | 3/7 | 5 |
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD3 genomes
Cov.:
26
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 26
GnomAD4 genome
Cov.:
26
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 02, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at